首页> 外文期刊>Antimicrobial agents and chemotherapy. >The transmission interface of the saccharomyces cerevisiae multidrug transporter Pdr5: Val-656 located in intracellular loop 2 plays a major role in Drug resistance
【24h】

The transmission interface of the saccharomyces cerevisiae multidrug transporter Pdr5: Val-656 located in intracellular loop 2 plays a major role in Drug resistance

机译:啤酒酵母多药转运蛋白Pdr5:Val-656的传输界面位于细胞内环2中,在耐药中起主要作用

获取原文
获取原文并翻译 | 示例
           

摘要

Pdr5 is a major ATP-binding cassette (ABC) multidrug transporter regarded as the founding member of a fungal subfamily of clinically significant efflux pumps. When these proteins are overexpressed, they confer broad-spectrum ultraresistance. To better understand the evolution of these proteins under selective pressure, we exposed a Saccharomyces cerevisiae yeast strain already overexpressing Pdr5 to a lethal concentration of cycloheximide. This approach gave mutations that confer greater resistance to a subset of transport substrates. One of these mutations, V656L, is located in intracellular loop 2 (ICL2), a region predicted by structural studies with several other ABC transporters to play a critical role in the transmission interface between the ATP hydrolysis and drug transport domains. We show that this mutation increases drug resistance, possibly by altering the efficiency with which the energy from ATP hydrolysis is used for transport. Val-656 is a conserved residue, and an alanine substitution creates a nearly null phenotype for drug transport as well as reduced ATPase activity. We posit that despite its unusually small size, ICL2 is part of the transmission interface, and that alterations in this pathway can increase or decrease resistance to a broad spectrum of drugs.
机译:Pdr5是一种主要的ATP结合盒(ABC)多药转运蛋白,被认为是具有临床意义的外排泵真菌亚科的创始成员。当这些蛋白过表达时,它们将赋予广谱超抗性。为了更好地了解这些蛋白质在选择性压力下的进化,我们将已经过量表达Pdr5的酿酒酵母酵母菌株暴露于致死浓度的环己酰亚胺。这种方法产生的突变赋予对运输底物的一部分更大的抵抗力。这些突变之一是V656L,位于细胞内环2(ICL2)中,该区域是通过结构研究与其他几种ABC转运蛋白预测的,在ATP水解和药物转运结构域之间的转运界面中起关键作用。我们表明,这种突变可能会通过改变ATP水解产生的能量用于运输的效率来提高耐药性。 Val-656是一个保守的残基,丙氨酸取代会产生几乎无效的药物转运表型以及降低的ATPase活性。我们认为,尽管ICL2的尺寸非常小,但它仍是传输界面的一部分,并且该途径的改变会增加或降低对多种药物的耐药性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号